2,2-Dimethyl-6,6-diphenylhexan-3-one | 94743-28-9

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: 2,2-Dimethyl-6,6-diphenylhexan-3-one
• CAS: 94743-28-9
• 化学式: C₂₀H₂₄O
• 分子量: 280.41
• InChiKey: DQUFZSJCDRKSRY-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  5
• 重原子数：
  21
• 可旋转键数：
  6
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.35
• 拓扑面积：
  17.1
• 氢给体数：
  0
• 氢受体数：
  1

反应信息

• 作为反应物：
  描述：

  2,2-Dimethyl-6,6-diphenylhexan-3-one 在 溴 、 sodium hydride 作用下， 反应 21.67h， 生成 1-(5,5-Dimethyl-4-oxo-1,1-diphenylhexan-3-yl)-3-(2,3-dimethylphenyl)quinazoline-2,4-dione
  参考文献：
  名称：

  Montignoul, Claude; Richard, Marie-Josee; Vigne, Christian, Journal of Heterocyclic Chemistry, 1984, vol. 21, p. 1509 - 1519

  摘要：

  DOI：
• 作为产物：
  描述：

  氯代叔丁烷 、 Chlorure de l' acide diphenyl-4,4 butyrique 在 铜 、 magnesium 、 copper(l) chloride 作用下， 生成 2,2-Dimethyl-6,6-diphenylhexan-3-one
  参考文献：
  名称：

  Montignoul, Claude; Richard, Marie-Josee; Vigne, Christian, Journal of Heterocyclic Chemistry, 1984, vol. 21, p. 1509 - 1519

  摘要：

  DOI：

文献信息

• FUNCTIONALLY-MODIFIED OLIGONUCLEOTIDES AND SUBUNITS THEREOF
  申请人：Sarepta Therapeutics, Inc.

  公开号：US20140330006A1

  公开（公告）日：2014-11-06

  Functionally-modified oligonucleotide analogues comprising modified intersubunit linkages and/or modified 3′ and/or 5′-end groups are provided. The disclosed compounds are useful for the treatment of diseases where inhibition of protein expression or correction of aberrant mRNA splice products produces beneficial therapeutic effects.

  提供了包含修改的亚单位间连接和/或修改的3'和/或5'-末端基团的功能修饰寡核苷酸类似物。所公开的化合物对于治疗需要抑制蛋白质表达或纠正异常mRNA剪接产物以产生有益治疗效果的疾病是有用的。
• OLIGONUCLEOTIDE ANALOGUES HAVING MODIFIED INTERSUBUNIT LINKAGES AND/OR TERMINAL GROUPS
  申请人：Hanson Gunnar J.

  公开号：US20120065169A1

  公开（公告）日：2012-03-15

  Oligonucleotide analogues comprising modified intersubunit linkages and/or modified 3′ and/or 5′-end groups are provided. The disclosed compounds are useful for the treatment of diseases where inhibition of protein expression or correction of aberrant mRNA splice products produces beneficial therapeutic effects.

  提供了包含修改的亚单位连接和/或修改的3'和/或5'-末端基团的寡核苷酸类似物。所披露的化合物对于治疗需要抑制蛋白质表达或纠正异常mRNA剪接产物以产生有益治疗效果的疾病非常有用。
• PEPTIDE OLIGONUCLEOTIDE CONJUGATES
  申请人：Hanson Gunnar J.

  公开号：US20120289457A1

  公开（公告）日：2012-11-15

  Oligonucleotide analogues conjugated to carrier peptides are provided. The disclosed compounds are useful for the treatment of various diseases, for example diseases where inhibition of protein expression or correction of aberrant mRNA splice products produces beneficial therapeutic effects.

  提供了与载体肽共轭的寡核苷酸类似物。所公开的化合物可用于治疗各种疾病，例如抑制蛋白质表达或校正异常的mRNA剪接产物可产生有益的治疗效果的疾病。
• dsRNA molecules comprising oligonucleotide analogs having modified intersubunit linkages and/or terminal groups
  申请人：Iversen Patrick L.

  公开号：US10017763B2

  公开（公告）日：2018-07-10

  Morpholino oligomers containing modified intersubunit linkages and/or terminal groups are provided for use within dsRNA molecules. The oligomers are oligonucleotide analogs containing predetermined sequences of base-pairing moieties. Also provided are such oligomers conjugated to peptide transporter moieties, where the transporters are preferably composed of arginine subunits, or arginine dimers, alternating with neutral amino acid subunits.

  Morpholino 寡聚物含有修饰的亚基间连接和/或末端基团，可用于 dsRNA 分子。这些寡聚物是含有预定碱基配对分子序列的寡核苷酸类似物。还提供了与肽转运体分子连接的此类寡聚体，其中转运体最好由精氨酸亚基或精氨酸二聚体组成，与中性氨基酸亚基交替使用。
• Oligonucleotide analogues having modified intersubunit linkages and/or terminal groups
  申请人：Sarepta Therapeutics, Inc.

  公开号：US10202602B2

  公开（公告）日：2019-02-12

  Oligonucleotide analogs comprising modified intersubunit linkages and/or modified 3′ and/or 5′-end groups are provided. The disclosed compounds are useful for the treatment of diseases where inhibition of protein expression or correction of aberrant mRNA splice products produces beneficial therapeutic effects.

  提供了包含修饰的亚基间连接和/或修饰的 3′和/或 5′末端基团的寡核苷酸类似物。所公开的化合物可用于治疗抑制蛋白质表达或校正异常 mRNA 剪接产物产生有益治疗效果的疾病。